A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma.

about

A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma.

Item

http://www.wikidata.org/entity/Q40392229

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

A concurrent ultra-fractionate ...... osed, inoperable glioblastoma.

@en

type

Item

label

A concurrent ultra-fractionate ...... osed, inoperable glioblastoma.

@en

prefLabel

A concurrent ultra-fractionate ...... osed, inoperable glioblastoma.

@en

P1476

A concurrent ultra-fractionate ...... nosed, inoperable glioblastoma

@en

P2093

C Carnin

http://www.w3.org/2001/XMLSchema#string

G Faure

http://www.w3.org/2001/XMLSchema#string

P Beauchesne

http://www.w3.org/2001/XMLSchema#string

P Quetin

http://www.w3.org/2001/XMLSchema#string

T Gorlia

http://www.w3.org/2001/XMLSchema#string

V Bernier

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches

Primary brain tumours in adults.

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.

Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.

Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy.

Low-dose hypersensitivity: current status and possible mechanisms.

P304

1538-1544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.29898

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

Véronique Quillien

R Pedeux

Georges Noel

P577

2015-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26501997

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy